Financials
Financial year 2025
Dr. Kim Taeymans from Mechelen, company number BE0767649684, closed financial year 2025 with a result of € 195,391 after tax. For that financial year Dr. Kim Taeymans recorded a gross margin of € 257,869 and equity of € 197,891. Compared with financial year 2024, the result moved from € 212,170 to € 195,391. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 15, 2026.
€ 197,891
▲ € 180,092 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 195,391
▼ 8% vs 2024
Profit after tax over the fiscal year.
€ 197,238
▲ 102% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 15,300 paid out
8 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
€ 5,698
▲ € 4,307 vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 82
▲ 109% vs 2024
Loans from banks and other lenders, long and short.
€ 667
▼ 41% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 7,087
▲ 63% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 152,680 | € 153,215 | € 279,641 | € 257,869 | ▼ 8% |
| Profit after taxes | € 116,012 | € 116,567 | € 212,170 | € 195,391 | ▼ 8% |
| Equity | € 166,063 | € 270,630 | € 17,800 | € 197,891 | ▲ € 180,092 |
| Total debts | € 9,324 | € 6,583 | € 205,509 | € 22,962 | ▼ 89% |
| Cash | € 158,535 | € 116,159 | € 97,698 | € 197,238 | ▲ 102% |
| Retained profit | € 163,563 | € 268,130 | € 15,300 | € 195,391 | ▲ € 180,092 |
| Dividend | € 0 | € 12,000 | € 465,000 | € 15,300 | ▼ 97% |
| Bank debt | € 0 | € 0 | € 39 | € 82 | ▲ 109% |
| Balance sheet total | € 175,387 | € 277,213 | € 223,309 | € 220,854 | ▼ 1% |
Key figures of Dr. Kim Taeymans, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about Dr. Kim Taeymans the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to Dr. Kim Taeymans?
What happened at Dr. Kim Taeymans in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 195,391 (▼ 8% vs 2024). Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Mechelen. KBO
In short
From € 116,012 profit in 2022 to € 195,391 profit in 2025.
Paid € 196,903 in corporate taxes since 2022.
Best year ever: 2024, with € 212,170 profit.
Paid out € 492,300 in dividends to the owners in total.
Management
Behind Dr. Kim Taeymans is Kim Taeymans.
Directors
According to the 2025 annual accounts
Kim Taeymans
Director
Establishments
Establishment units
Physical locations of this company
Zandstraat 49
2800 Mechelen
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- Kim Taeymans(oprichter) 100%
Details
- Company number
- 0767.649.684
- VAT number
- BE 0767.649.684
- Registered office
- Zandstraat 49, 2800 Mechelen
- Names & denominations
- Dr. Kim Taeymans
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 29 April 2021
- Peppol
- Active · Active since 26 Nov 2025